Expression of GnTIII in a recombinant anti‐CD20 CHO production cell line: Expression of antibodies with altered glycoforms leads to an increase in ADCC through higher affinity for FCγRIII

Davies, Julian, Jiang, LiYing, Pan, Li‐Zhen, LaBarre, Michael J., Anderson, Darrell, Reff, Mitchell·2001·Biotechnology and Bioengineering
DOI 10.1002/bit.1119

Cited by (327)

Items 201–300 of 327

  1. Immunotherapy with anti-CD20 compounds
    Christoph von Schilling · 2003 · Seminars in Cancer Biology
  2. Identifying the differences in mechanisms of mycophenolic acid controlling fucose content of glycoproteins expressed in different CHO cell lines
    An Zhang, Valerie Liu Tsang, Lam Raga A. Markely, Lutfiye Kurt, Yao‐ming Huang, Shashi Prajapati, Rashmi Kshirsagar · 2016 · Biotechnology and Bioengineering
  3. IgG and leukocytes: Targets of immunomodulatory α2,6 sialic acids
    Mark B. Jones · 2018 · Cellular Immunology
  4. Effect of the conserved oligosaccharides of recombinant monoclonal antibodies on the separation by protein A and protein G chromatography
    Georgeen Gaza‐Bulseco, Keith Hickman, Sara L. Sinicropi-Yao, Karen Hurkmans, Chris M. Chumsae, Hongcheng Liu · 2009 · Journal of Chromatography A
  5. Antibody Structures
    Yoshiki Yamaguchi, Naoki Takahashi, Koichi Kato · 2007 · Elsevier eBooks
  6. Antibody-drug conjugates for cancer therapy: An up-to-date review on the chemistry and pharmacology
    Amol Dilip Gholap, Juhi S. Gupta, Pallavi A. Kamandar, Gauri V. Banchhod, Navnath Tulshiram Hatvate · 2023 · Comprehensive analytical chemistry
  7. Escherichia coli and Pichia pastoris : microbial cell-factory platform for full-length IgG production
    Shyam Krishna, Sang Taek Jung, Eun Yeol Lee · 2024 · Critical Reviews in Biotechnology
  8. The War Is on: The Immune System against Glioblastoma—How Can NK Cells Drive This Battle?
    Lucas Henrique Rodrigues da Silva, Luana Correia Croda Catharino, Viviane Jennifer da Silva, Gabriela C. M. Evangelista, José Alexandre Marzagão Barbuto · 2022 · Biomedicines
  9. The Importance of Glycosylation in COVID-19 Infection
    Tea Pribić, Gordan Lauc, Irena Trbojević‐Akmačić · 2021 · Advances in experimental medicine and biology
  10. Systems Glycobiology: Immunoglobulin G Glycans as Biomarkers and Functional Effectors in Aging and Diseases
    Marina Martinić Kavur, Gordan Lauc, Marija Pezer · 2021 · Elsevier eBooks
  11. Genetic modification of a chicken expression system for the galactosylation of therapeutic proteins produced in egg white
    Akifumi Mizutani, 裕之 綱島, Ken-ichi Nishijima, Takako Sasamoto, Yuki Yamada, Yasuhiro Kojima, Makoto Motono, Jun Kojima, Yujin Inayoshi, Katsuhide Miyake et al. · 2011 · Transgenic Research
  12. High-throughput N-glycan analysis in aging and inflammaging: State of the art and future directions
    Ana Cindrić, Tea Pribić, Gordan Lauc · 2024 · Seminars in Immunology
  13. Glycosylation States on Intact Proteins Determined by NMR Spectroscopy
    Audra A. Hargett, Aaron M. Marcella, Huifeng Yu, Chao Li, Jared Orwenyo, Marcos D. Battistel, Lai‐Xi Wang, Darón I. Freedberg · 2021 · Molecules
  14. ADCC enhancement: A conundrum or a boon to mAb therapy?
    Aditya Narvekar, Apurva Pardeshi, Ratnesh D. Jain, Prajakta P. Dandekar · 2022 · Biologicals
  15. Glycosylation of Therapeutic IgGs
    Yusuke Mimura, Roy Jefferis, Yuka Mimura‐Kimura, Jodie L. Abrahams, Pauline Mary Rudd · 2009
  16. Sweet Rules: Linking Glycosylation to Antibody Function
    Falk Nimmerjahn, Anja Werner · 2021 · Experientia supplementum
  17. Advances of research of Fc-fusion protein that activate NK cells for tumor immunotherapy
    Yan-Xin Niu, Zhaoxu Xu, Lifeng Yu, Yongping Lu, Yan Wang, Ce Wu, Yi-Bo Hou, Jianing Li, Shengqiang Huang, Xinyue Song et al. · 2022 · International Immunopharmacology
  18. Humanization of recombinant glycoproteins expressed in insect cells
    Noboru Tomiya · 2009 · Trends in Glycoscience and Glycotechnology
  19. Tailoring immunoglobulin Fc for highly potent and serum-stable therapeutic antibodies
    Sang Taek Jung · 2013 · Biotechnology and Bioprocess Engineering
  20. Phage display generation of a novel human anti‐ CD 1 A monoclonal antibody with potent cytolytic activity
    Gitanjali I. Bechan, David W. Lee, Dirk M. Zajonc, Diana Heckel, Rena R. Xian, Mark Throsby, Marja van Meijer, Wilfred T.V. Germeraad, Anna M. Kruisbeek, Rudolph Maarten Egeler et al. · 2012 · British Journal of Haematology
  21. Bisecting N-Acetylglucosamine of the N-Glycan of Immunoglobulin G Does Not Affect Binding to Fc Gamma Receptors
    Gerlof P. Bosman, Inèz D. Stoof, Hans P. Bastiaansen, Linda Quarles van Ufford, Justyna M. Dobruchowska, Jan-Willem H. Langenbach, Bhargavi M. Boruah, Kelley W. Moremen, Arthur E. H. Bentlage, Suzanne N. Lissenberg‐Thunnissen et al. · 2025 · ACS Chemical Biology
  22. New Alternatives for Autoimmune Disease Treatments: Physicochemical and Clinical Comparability of Biosimilar Etanercept
    Mariana P. Miranda‐Hernández, Carlos A. López‐Morales, Francisco C. Perdomo‐Abúndez, Rodolfo Daniel Salazar-Flores, Nancy D. Ramírez-Ibáñez, Néstor O. Pérez, Aarón Molina-Pérez, Jorge Revilla-Beltri, Luis Francisco Flores-Ortiz, Emilio Medina‐Rivero · 2016 · Journal of Immunology Research
  23. Analytical characterization of ch14.18
    Gopalan Soman, Abraham T. Kallarakal, Dennis F. Michiel, Xiaoyi Yang, Nirmala Saptharish, Hengguang Jiang, S L Giardina, John A. Gilly, George Mitra · 2012 · mAbs
  24. Glycoengineering and glycosite-specific labeling of serum IgGs from various species
    Weilai Guo, Feng Tang, Ken Qin, Mang Zhou, Zhiping Le, Wei Huang · 2017 · Carbohydrate Research
  25. Human Antiglobulin Responses
    Lorin K. Roskos, Sirid‐Aimée Kellermann, Kenneth A. Foon · 2005 · Elsevier eBooks
  26. Function characterization of a glyco-engineered anti-EGFR monoclonal antibody cetuximab in vitro
    Changhong Yi, Canping Ruan, Hao Wang, Xinyun Xu, Yunpeng Zhao, Meng Fang, Jun Ji, Xing Gu, Chunfang Gao · 2014 · Acta Pharmacologica Sinica
  27. Fully galactosyl-fucosyl-bisected IgG1 reduces anti-HBV efficacy and liver histological improvement
    Cheng-Hsun Ho, Shu‐Hui Chen, Hung‐Wen Tsai, I‐Chin Wu, Ting‐Tsung Chang · 2019 · Antiviral Research
  28. Comparative N-Glycosylation Analysis of the Fc Portions of a Chimeric Human Coagulation Factor VIII and Immunoglobulin G1
    Christoph Kannicht, Mario Kröning, Barbara Solecka-Witulska, Guido Kohla, Julia Rosenlöcher · 2017 · Bioengineering
  29. Therapeutic Antibodies
    Mitsuo Satoh, Kenya Shitara, Nobuo Hanai · 2007 · Elsevier eBooks
  30. Immunoglobulin G Glycosylation Changes in Aging and Other Inflammatory Conditions
    Fabio Dall’Olio, Nadia Malagolini · 2021 · Experientia supplementum
  31. CHO Cell Engineering for Improved Process Performance and Product Quality
    Simon Fischer, Kerstin Otte · 2019
  32. Recent Advances in Glycosylation Modifications in the Context of Therapeutic Glycoproteins
    Xiaotian Zhong, Will Somers · 2012 · InTech eBooks
  33. Identification of Novel Neutralizing Monoclonal Antibodies against SARS-CoV-2 Spike Glycoprotein
    Devivasha Bordoloi, Ziyang Xu, Michelle Ho, Mansi Purwar, Pratik Sanjivkumar Bhojnagarwala, Joel A. Cassel, Leila B. Giron, Susanne N. Walker, Abhijeet J. Kulkarni, Edgar Tello‐Ruiz et al. · 2021 · ACS Pharmacology & Translational Science
  34. Analysis of 2-aminopyridine labeled glycans by dual-mode online solid phase extraction for hydrophilic interaction and reversed-phase liquid chromatography
    Kishimoto Yuka, Fuka Okada, Tomohiro Maesako, Sachio Yamamoto, Mitsuhiro Kinoshita, Takao Hayakawa, Shigeo Suzuki · 2020 · Journal of Chromatography A
  35. A Chromatographic Approach for Elevating the Antibody-Dependent Cellular Cytotoxicity of Antibody Composites
    Setsuko Tojo, Akira Okazaki, Masako Wakitani, Toyohide Shinkawa, Kazuhisa Uchida, Toshiyuki Suzawa · 2009 · Biological and Pharmaceutical Bulletin
  36. Impact of Fc Glycosylation on Monoclonal Antibody Effector Functions and Degradation by Proteases
    T. Shantha Raju · 2009 · Springer eBooks
  37. Engineering the Antibody Fc Region for Optimal Effector Function
    Greg A. Lazar, John R. Desjarlais · 2009
  38. Therapeutic proteins: facing the challenges of glycobiology
    Simone Albrecht, Mark Hilliard, Pauline Mary Rudd · 2014 · Journal of Health Policy & Outcomes Research
  39. Two Are Better than One: The Bi-Specific Antibody Mosunetuzumab Reveals an Improved Immune Response of Vγ9Vδ2 T Cells Targeting CD20 in Malignant B Cells in Comparison to the Mono-Specific Antibody Obinutuzumab
    Lothar Marischen, Jürgen H. Fritsch, Jovana Ilic, Laura Wahl, Thomas Bertsch, Stefan Tobias Knop, Anna Bold · 2025 · International Journal of Molecular Sciences
  40. Discrimination between glycosylation patterns of therapeutic antibodies using a microfluidic platform, MALDI-MS and multivariate statistics
    Trần Thi Thúy, Erik Tengstrand, Magnus Åberg, Gunnar Thorsén · 2012 · Journal of Pharmaceutical and Biomedical Analysis
  41. Immunotherapeutic Approaches for the Control and Eradication of HIV
    Daniel Amsterdam · 2015 · Immunological Investigations
  42. Metabolic engineering of CHO cells to prepare glycoproteins
    Qiong Wang, Michael J. Betenbaugh · 2018 · Emerging Topics in Life Sciences
  43. Application of Genetic Engineering in Biotherapeutics Development
    Patrick G. Schweickert, Zhuo Cheng · 2019 · Journal of Pharmaceutical Innovation
  44. APPLICATION OF IMMUNOGLOBULIN-BINDING PROTEINS A, G, L IN THE AFFINITY CHROMATOGRAPHY
    О. В. Святенко · 2014 · Biotechnologia Acta
  45. Capillary Electrophoresis of Carbohydrates
    Kazuaki Kakehi, Shigeo Suzuki · 2007 · Elsevier eBooks
  46. Low-concentration staurosporine improves recombinant antibody productivity in Chinese hamster ovary cells without inducing cell death
    Masahide Kido, Hideaki Idogaki, Kouji Nishikawa, Takeshi Ōmasa · 2020 · Journal of Bioscience and Bioengineering
  47. Recombinant IgA Antibodies
    Esther M. Yoo, Koteswara R. Chintalacharuvu, Sherie Leaver Morrison · 2007 · Springer eBooks
  48. Application of a Reversible Immortalization System for the Generation of Proliferation-Controlled Cell Lines
    Tobias May, Werner Lindenmaier, Dagmar Wirth, Peter P. Mueller · 2004 · Cytotechnology
  49. Immunoglobulin G N-glycan signatures as potential diagnostic and predictive biomarkers for non-small-cell lung cancer
    Yi Wang, Yuting Feng, Jiaoyuan Li, Tongxin Yin, Yuanyuan Liu, Qiankun Wang, Xiao Xiao, Huihao Ren, Si Liu, Xin Liu et al. · 2025 · International Journal of Biological Macromolecules
  50. Next-Generation Cell Engineering Platform for Improving Recombinant Protein Production in Mammalian Cells
    Sung Wook Shin, Minji Kyeong, Jae Seong Lee · 2021 · Cell engineering
  51. Serum disease-specific IgG Fc glycosylation as potential biomarkers for nonproliferative diabetic retinopathy using mass spectrometry
    Yixin Zhang, Zhizhen Lai, Zhonghao Yuan, Bin Qu, Yan Li, Wenyu Yan, Bing Li, Weihong Yu, Shanjun Cai, Hua Zhang · 2023 · Experimental Eye Research
  52. Combinatory glycoengineering of monoclonal antibodies and its application in cancer therapy: a narrative review
    Siyuan Wang, Huairu Tian, Peilin Tian, Yiwen Xing, Yuan Zeng · 2024 · Translational Cancer Research
  53. A MUC16 IgG Binding Activity Selects for a Restricted Subset of IgG Enriched for Certain Simian Immunodeficiency Virus Epitope Specificities
    Jeffrey R. Schneider, Xiaoying Shen, Chiara Orlandi, Tinashe E. Nyanhete, Sheetal S. Sawant, Ann M. Carias, Archer D. Smith, Neil L. Kelleher, Ronald S. Veazey, George K. Lewis et al. · 2019 · Journal of Virology
  54. Mammalian Cell Lines and Glycosylation: A Case Study
    Michael Butler · 2009 · Wiley eBooks
  55. Molecular Engineering III: Fc Engineering
    Matthias Peipp, Thomas D. Beyer, Michael Dechant, Thomas Valerius · 2007
  56. Batch‐to‐batch variability of two human designer cell lines – AGE 1. HN and AGE 1. HN . AAT – carried out by different laboratories under defined culture conditions using a mathematical model
    Susann Freund, Alexander Rath, Oscar Platas Barradas, Eva Skerhutt, Sebastian Scholz, Jens Niklas, Volker Sandig, Thomas Rose, Elmar Heinzle, Thomas Noll et al. · 2013 · Engineering in Life Sciences
  57. Monoclonal Antibodies: Mechanisms of Action
    Roy Jefferis · 2014 · ACS symposium series
  58. Long-Term Culturing of FreeStyle 293-F Cells Affects Immunoglobulin G Glycome Composition
    Fran Lukšić, Anika Mijakovac, Goran Josipović, Vedrana Vičić Bočkor, Jasminka Krištić, Ana Cindrić, Martina Vinicki, Filip Rokić, Oliver Vugrek, Gordan Lauc et al. · 2023 · Biomolecules
  59. Opportunities to Exploit Antibody Glycosylation in Vaccination
    Nickita Mehta, Galit Alter · 2017 · Future Virology
  60. Optimizing Chinese hamster ovary cell line development via targeted control of N-glycosylation
    Christina S. Alves, Shashi Prajapati · 2015 · Pharmaceutical Bioprocessing
  61. Glycosylation of Recombinant IgG Antibodies and Its Relevance for Therapeutic Applications
    Roy Jefferis · 2002 · Cell engineering
  62. Engineer Medium and Feed for Modulating N-Glycosylation of Recombinant Protein Production in CHO Cell Culture
    Yuzhou Fan, Helene Faustrup Kildegaard, Mikael Rørdam Andersen · 2017 · Methods in molecular biology
  63. Immunoglobulin G Glycosylation in Diseases
    Marija Pezer · 2021 · Experientia supplementum
  64. Protein Glycosylation: Analysis, Characterization, and Engineering
    Mikael Rørdam Andersen, Jong Hyun Nam, Susan T. Sharfstein · 2011 · Encyclopedia of Industrial Biotechnology
  65. Programmable Chemoenzymatic Assembly of a Bisected and Core‐Fucosylated N ‐Glycan Library Reveals Glycan‐Binding Protein Specificity and Branch Preference
    Jialin Liu, Wei Zhang, Zhuojia Xu, Yi Huang, Wenjing Ma, Xi Cheng, Tiehai Li · 2025 · Angewandte Chemie International Edition
  66. Genetic insights into across pancreatitis types: the causal influence of immunoglobulin G N-glycosylation variants on disease risk
    Yulin Chen, Xue Li, Ran Lu, Yinchun Lv, Junman Ye, Qiaorong Huang, Wentong Meng, Feiwu Long, Jonas Burman, Xianming Mo et al. · 2024 · Frontiers in Immunology
  67. The Autophagy Inhibitor Bafilomycin Inhibits Antibody-Dependent Natural Killer Cell-Mediated Killing of Breast Carcinoma Cells
    Bede Ákos Máté, Váróczy Csongor Attila, Zsuzsanna Polgár, Gergő Fazekas, Csaba Hegedűs, Endre Kókai, Katalin Éva Kovács, László Virág · 2025 · International Journal of Molecular Sciences
  68. The effect of n-3 polyunsaturated fatty acids-enriched hen eggs consumption on IgG and total plasma protein N-glycosylation in healthy individuals and cardiovascular patients
    Ana Stupin, Ana Cvetko, Gordana Kralik, Martina Mihalj, Petar Šušnjara, Nikolina Kolobarić, Željka Breškić Ćurić, Ana Marija Lukinac, Aleksandar Kibel, Kristina Selthofer-Relatić et al. · 2021 · Glycobiology
  69. Human IgG Glycosylation in Inflammation and Inflammatory Disease
    Yusuke Mimura, Roy Jefferis · 2020 · Elsevier eBooks
  70. Glycoengineering: Recombinant Glycoproteins
    Michael J. Betenbaugh, Noboru Tomiya, Someet Narang · 2007 · Elsevier eBooks
  71. Immune Responses to Viral Infection
    Hendrik Streeck, Todd J. Suscovich, Galit Alter · 2016 · ASM Press eBooks
  72. Glycosylation of Antibody Molecules
    Roy Jefferis · 2014
  73. Considerations for Glycoprotein Production
    Elizabeth C. Clarke · 2024 · Methods in molecular biology
  74. Programmable Chemoenzymatic Assembly of a Bisected and Core‐Fucosylated N ‐Glycan Library Reveals Glycan‐Binding Protein Specificity and Branch Preference
    Jialin Liu, Wei Yan Zhang, Zhuojia Xu, Yi Huang, Wenjing Ma, Xi Cheng, Tiehai Li · 2025 · Angewandte Chemie
  75. Golgi engineering of CHO cells by targeted integration of glycosyltransferases leads to the expression of novel Asn-linked oligosaccharide structures at secretory glycoproteins
    Tobias Reinl, Nicolas Grammel, Sebastian Kandzia, Eckart Grabenhorst, Harald S. Conradt · 2013 · BMC Proceedings
  76. Significant Associations of IgG Glycan Structures With Chronic Graft-Versus-Host Disease Manifestations: Results of the Cross-Sectional NIH Cohort Study
    Ema Prenc, Dražen Pulanić, Maja Pučić‐Baković, Ivo Ugrina, Lana Desnica, Milan Milošević, Filip Pirsl, Sandra A. Mitchell, Jeremy J. Rose, Radovan Vrḫovac et al. · 2021 · Frontiers in Immunology
  77. Enhancement of effector functions of anti-CD20 monoclonal antibody by increased afucosylation in CHO cell line through cell culture medium optimization
    Bala Reddy Bheemareddy, Prakash Narayana Reddy, Kranthi Vemparala, Vijaya ramu Dirisala · 2022 · Journal of Genetic Engineering and Biotechnology
  78. Bioengineering for Production of Biologically Active Compounds in Plants
    Harsharan Singh · 2024 · Springer eBooks
  79. Glyco-engineering of Fc Glycans to Enhance the Biological Functions of Therapeutic IgGs
    T. Raju, D. Knight, R. Jordan · 2010 · Springer eBooks
  80. Industrial bioprocesses: Beyond routine applications of established methodologies
    Beth Junker · 2009 · Biotechnology and Bioengineering
  81. Characterizing the Glycosylation State of Therapeutic Recombinant Glycoproteins
    Nicole M. Samuels, David S. Kates, Jun Liu, Joanne C. Severs · 2012 · Methods in molecular biology
  82. The Discovery of Rituxan
    Mitchell E. Reff · 2006 · Informa Healthcare eBooks
  83. Online Cleanup Liquid Chromatography for the Analysis of Glycoprotein-Derived Oligosaccharides Labeled with 7-Amino-4-methylcoumarin
    Yoshie NAGATOMO, Shinichi Hashimoto, Kishimoto Yuka, Takao Hayakawa, Sachio Yamamoto, Mitsuhiro Kinoshita, Shigeo Suzuki · 2017 · Chromatography
  84. Association of the serum IgG glycosylation with disease activity of anti-transcription intermediary factor 1 gamma positive dermatomyositis
    Xi Li, Jingjing Bai, Siting Li, Mengtao Li, Xiaofeng Zeng, Qian Wang, Chaojun Hu · 2022 · Clinical and Experimental Rheumatology
  85. High level recombinant antibody production in Chinese hamster ovary (CHO) cells and characterisation of the carcinoembryonic antigen (CEA) specific human full-size IgG1 H10
    Anne Verena Peuscher, Rainer Fischer · 2011 · RWTH Publications (RWTH Aachen)
  86. Future Prospects in Antibody Engineering and Therapy
    Sophie Sibéril, Jean‐Luc Teillaud · 2004 · Springer eBooks
  87. Antibody Engineering
    Esther M. Yoo, Sherie Leaver Morrison · 2009 · Encyclopedia of Industrial Biotechnology
  88. Chemical Biology Study on N-glycans
    Yoshiyuki Manabe · 2021 · Trends in Glycoscience and Glycotechnology
  89. Optimization of culture condition for Spodoptera frugiperda by design of experiment approach and evaluation of its effect on the expression of hemagglutinin protein of influenza virus
    Fatemeh Alizadeh, Hamideh Aghajani, Fereidoun Mahboudi, Yeganeh Talebkhan, Ehsan Arefian, Sepideh Samavat, Rouhollah Raufi · 2024 · PLoS ONE
  90. Optimizing the preparation of labeled N-glycans for rapid, simplified, and high-precision analysis
    Riko Makino, Shunji Natsuka · 2025 · PLoS ONE
  91. N-Glycoengineering of insect cells for tri-antennary N-glycan biosynthesis
    Hiroyuki Kajiura, Naokuni Nishiguchi, Reimi Lai Sang Sawada‐Choi, Yuto Sana, Ryo Misaki, Kazuhito Fujiyama · 2026 · Scientific Reports
  92. Strategies for Development of Next Generation Antibody-Based Therapeutics
    Mohammad A. Tabrizi, Gadi Gazit Bornstein · 2012 · Springer eBooks
  93. Cutting back on the carbs
    Vivian H. Trang, Peter D. Senter · 2016 · Proceedings of the National Academy of Sciences
  94. Original drugs approved by the Food and Drug Administration (Center for Drug Evaluation and Research) in 2024
    Д. В. Куркин, Осадченко Назар Андреевич, A. R. Makarova, DARIA A. GALKINA, Dmitry Aleksandrovich Bakulin, Olga V. Shatalova, Andrey V. Strygin, Vladimir Ivanovich Petrov, O. V. Marincheva, Yu. V. Gorbunova et al. · 2025 · Pharmacy & Pharmacology
  95. Human IgG Glycosylation in Inflammation and Inflammatory Disease
    Roy Jefferis · 2007 · Elsevier eBooks
  96. Posttranslational Modifications to Improve Biopharmaceuticals
    Gary Walsh · 2013
  97. Characterization of Monoclonal Antibody Variants and Glycosylation
    Ting Zheng, Srinivasa Rao, Jeff S. Rohrer, Christopher A. Pohl · 2012
  98. 20 The Role of Glycosylation in Engineered Antibodies
    Sherie Leaver Morrison · 2005
  99. Immunomics: Entwicklung einer ESI-MS basierten Methodik zur Differenzierung und Quantifizierung von humanen Immunglobulinen und ihrer Glykosylierung
    Lejon Martens · 2003 · Kölner Universitäts PublikationsServer (Universität zu Köln)
  100. Cell Line and Cell Culture Development for Biosimilar Antibody‐Drug Manufacturing
    Jianguo Yang · 2016 · Wiley eBooks